PROMETIC’S PBI-4050’S POSITIVE SAFETY REVIEW TRIGGERS EXPANSION OF PHASE II CLINICAL TRIAL IN METABOLIC SYNDROME PATIENTS

August 27, 2015
Posted by: Prometic Prometic
Posted In: Press Releases 2015
X